down arrow

MDxHealth SA

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BE0974461940
USD
3.64
0.17 (4.9%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Ion Beam Applications SA
MDxHealth SA
Nyxoah SA
Sequana Medical NV
Biocartis Group NV
Why is MDxHealth SA ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 50.20% and Operating profit at 6.12% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.05
2
Flat results in Jun 25
  • INTEREST(Q) Highest at USD 6.29 MM
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 91.44%, its profits have risen by 4%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MDxHealth SA for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
MDxHealth SA
85.71%
3.70
58.55%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
50.20%
EBIT Growth (5y)
6.12%
EBIT to Interest (avg)
-2.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.89
Sales to Capital Employed (avg)
1.14
Tax Ratio
1.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
47.76%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
17.17
EV to EBIT
-5.30
EV to EBITDA
-8.69
EV to Capital Employed
6.60
EV to Sales
1.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-124.67%
ROE (Latest)
-649.58%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
NET PROFIT(HY)

Higher at USD -16.58 MM

OPERATING PROFIT(Q)

Highest at USD -0.21 MM

OPERATING PROFIT MARGIN(Q)

Highest at -0.79 %

RAW MATERIAL COST(Y)

Fallen by -11.47% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -5,798.41 %

NET SALES(Q)

Highest at USD 26.61 MM

-8What is not working for the Company
INTEREST(Q)

Highest at USD 6.29 MM

Here's what is working for MDxHealth SA
Operating Profit
Highest at USD -0.21 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at -0.79 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Net Profit
Higher at USD -16.58 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales
Highest at USD 26.61 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Debt-Equity Ratio
Lowest at -5,798.41 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -11.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 2.27 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for MDxHealth SA
Interest
At USD 6.29 MM has Grown at 21.56%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest
Highest at USD 6.29 MM
in the last five periods and Increased by 21.56% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."